Effect of Immunomodulators and Biologic Agents on Malignancy in Patients with Inflammatory Bowel Disease / 대한소화기학회지
The Korean Journal of Gastroenterology
;
: 162-168, 2017.
Article
in Korean
| WPRIM
| ID: wpr-119541
ABSTRACT
Immunosuppressive agents and biological agents are widely used for therapy in patients with inflammatory bowel disease (IBD). However, these therapies may be associated with an increased risk of malignancy. There is evidence that exposure of the therapeutic agents such as thiopurine and anti-tumor necrosis factor for IBD is associated with an increased risk of lymphoproliferative disorders, skin cancers, or uterine cervical cancers. This article reviews the malignancies associated with the use of immunosuppressive agents and biological agents in IBD.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Skin Neoplasms
/
Azathioprine
/
Inflammatory Bowel Diseases
/
Biological Factors
/
Uterine Cervical Neoplasms
/
Tumor Necrosis Factor-alpha
/
Immunologic Factors
/
Immunosuppressive Agents
/
Lymphoproliferative Disorders
/
Mercaptopurine
Limits:
Humans
Language:
Korean
Journal:
The Korean Journal of Gastroenterology
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS